Erhe Gao Selected Research

Ventricular Remodeling

10/2023	Excretory/secretory products from Trichinella spiralis adult worms ameliorate myocardial infarction by inducing M2 macrophage polarization in a mouse model.
9/2017	Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling.
1/2017	Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1.
1/2014	Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
1/2012	Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erhe Gao Research Topics

Disease

68	Myocardial Infarction 10/2023 - 09/2004
56	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 03/2002
44	Heart Failure 11/2023 - 09/2006
42	Infarction (Infarctions) 01/2023 - 10/2003
34	Reperfusion Injury 01/2023 - 05/2002
30	Ischemia 01/2023 - 05/2002
19	Fibrosis (Cirrhosis) 11/2023 - 10/2003
15	Cardiomegaly (Heart Hypertrophy) 01/2024 - 08/2008
14	Hypertrophy 01/2024 - 05/2010
14	Inflammation (Inflammations) 10/2023 - 12/2010
14	Hypoxia (Hypoxemia) 01/2023 - 09/2003
7	Heart Injuries 01/2023 - 02/2009
7	Cardiomyopathies (Cardiomyopathy) 01/2021 - 09/2006
5	Insulin Resistance 11/2023 - 05/2011
5	Ventricular Remodeling 10/2023 - 01/2012
5	Heart Diseases (Heart Disease) 01/2023 - 02/2009
5	Neoplasms (Cancer) 01/2022 - 07/2012
5	Atherosclerosis 12/2020 - 12/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2012
4	Body Weight (Weight, Body) 10/2023 - 10/2003
4	Left Ventricular Dysfunction 01/2023 - 07/2010
4	Myocardial Reperfusion Injury 03/2015 - 05/2002
3	Type 2 Diabetes Mellitus (MODY) 11/2021 - 03/2007
2	Hypoadiponectinemia 12/2023 - 01/2023
2	Diabetes Mellitus 01/2023 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 01/2016
2	Diabetic Cardiomyopathies 11/2021 - 09/2017
2	Cicatrix (Scar) 12/2020 - 10/2018
2	Necrosis 01/2019 - 05/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
15	AdiponectinIBA 12/2023 - 03/2007
10	Small Interfering RNA (siRNA)IBA 11/2023 - 10/2012
9	salicylhydroxamic acid (SHAM)IBA 01/2023 - 10/2003
9	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 12/2010
8	G-Protein-Coupled Receptor Kinase 2IBA 01/2017 - 08/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2011
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 10/2010
7	MelatoninIBA 01/2020 - 01/2016
6	Peptides (Polypeptides)IBA 01/2024 - 08/2008
6	Caspase 3 (Caspase-3)IBA 04/2014 - 08/2004
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2010 - 03/2002
5	Insulin (Novolin)FDA Link 11/2023 - 03/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2012
5	Tamoxifen FDA LinkGeneric 11/2019 - 08/2008
5	AdipokinesIBA 08/2019 - 08/2011
5	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2018 - 10/2010
5	Superoxides (Superoxide)IBA 01/2018 - 03/2007
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2024 - 01/2013
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023 - 05/2005
4	G-Protein-Coupled Receptor Kinase 5IBA 01/2022 - 09/2012
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 09/2017
4	AMP-Activated Protein KinasesIBA 01/2019 - 02/2009
4	Peroxynitrous Acid (Peroxynitrite)IBA 03/2009 - 08/2006
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2024 - 09/2012
3	Atrial Natriuretic Factor (ANF)IBA 01/2024 - 01/2018
3	Caveolin 3IBA 11/2023 - 04/2012
3	CytokinesIBA 10/2023 - 08/2014
3	LipidsIBA 01/2023 - 12/2020
3	Phosphates (Orthophosphate)IBA 01/2023 - 11/2019
3	Adiponectin ReceptorsIBA 01/2022 - 09/2011
3	Azithromycin (Zithromax)FDA LinkGeneric 03/2021 - 01/2018
3	CatecholaminesIBA 01/2021 - 05/2010
3	Messenger RNA (mRNA)IBA 01/2021 - 05/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020 - 04/2013
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 12/2003
3	CateninsIBA 01/2020 - 02/2012
3	Protein Isoforms (Isoforms)IBA 01/2016 - 02/2014
3	beta Adrenergic ReceptorsIBA 10/2015 - 08/2006
3	Etanercept (Enbrel)FDA Link 06/2015 - 08/2011
3	Glycogen Synthase (Synthase I)IBA 01/2014 - 05/2010
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013 - 03/2009
3	ThioredoxinsIBA 10/2012 - 08/2004
3	Rosiglitazone (Avandia)FDA Link 03/2010 - 04/2004
3	PPAR-gamma AgonistsIBA 02/2010 - 12/2003
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2024 - 04/2012
2	UbiquitinIBA 01/2024 - 09/2020
2	Glycogen Synthase KinasesIBA 01/2024 - 01/2016
2	Therapeutic UsesIBA 10/2023 - 10/2018
2	Interleukin-10 (Interleukin 10)IBA 10/2023 - 06/2019
2	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2014
2	InflammasomesIBA 12/2021 - 01/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2020
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 07/2007
2	CaspasesIBA 12/2020 - 01/2005
2	Peptide Hydrolases (Proteases)FDA Link 12/2020 - 01/2005
2	Circular RNAIBA 01/2020 - 01/2019
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 09/2013
2	HydrogelsIBA 01/2020 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2019
2	Branched-Chain Amino AcidsIBA 01/2020 - 11/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2018
2	Angiotensin IIIBA 01/2019 - 01/2018
2	Conditioned Culture MediaIBA 01/2018 - 06/2012

Therapy/Procedure

25	Therapeutics 12/2023 - 05/2007
14	Ligation 01/2023 - 10/2003
8	Transplantation 11/2023 - 09/2004
3	Injections 01/2023 - 01/2018
2	Cell Transplantation 10/2018 - 06/2015